DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728
Document and Entity Information - USD ($)
12 Months Ended
Jun. 30, 2017
Nov. 20, 2017
Dec. 31, 2016
Document and Entity Information [Abstract]      
Entity Registrant Name DanDrit Biotech USA, Inc.    
Entity Central Index Key 0001527728    
Trading Symbol DDRT    
Amendment Flag true    
Amendment Description

Dandrit Biotech USA Inc. (the “Company,” “we,” “us,” or “our”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its annual report on Form 10-K for the fiscal year ended June 30, 2017, which was originally filed September 29, 2017 (the “Original Filing”), to amend and restate Item 1of Part I, “Business”; Item 5 of Part II “Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities”; Item 7 of Part II, “ Management’s Discussion and Analysis of Financial Condition and Results of Operations”; Item 8 of Part II, “Financial Statements and Supplementary Data” with respect to (1) the engagement of a consultant on April 21, 2017 and the compensation valuation of the 200,000 common shares of the Company’s common stock (2) disclosure of significant account policies related to Nonemployee Share-Based Payments and (3) to update certain subsequent events; and Item 13 of Part II “Certain Relationships and Related Transactions and Director Independence”.


As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), new certifications of our principal executive officer and principal financial officer are also being filed as exhibits to this Amendment. This Amendment should be read in conjunction with the Original Filing, which continues to speak as of the date of the Original Filing. The Amendment does include changes to the consolidated financial statements and, modifies or updates disclosures in the Original Filing.  Accordingly, this Amendment does not reflect events occurring after the filing of the Original Filing.

Current Fiscal Year End Date --06-30    
Document Type 10-K    
Document Period End Date Jun. 30, 2017    
Document Fiscal Year Focus 2017    
Document Fiscal Period Focus FY    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 5,472,912
Entity Common Stock Shares Outstanding   13,727,538